IP Library › Assignment 063061/0245

Patent Assignment

Reel/Frame 063061/0245

Assignment of Assignor's Interest

Recorded: 2023-03-22 Pages: 5

View PDF Order Certified Copy

Assignors

MAIER, MARTIN

Executed: 2017-05-15

FOSTER, DON

Executed: 2017-06-27

MILSTEIN, STUART

Executed: 2017-07-12

KUCHIMANCHI, SATYA

Executed: 2017-06-22

JADHAV, VASANT

Executed: 2017-05-16

RAJEEV, KALLANTHOTTATHIL G.

Executed: 2017-07-12

MANOHARAN, MUTHIAH

Executed: 2017-05-15

PARMAR, RUBINA

Executed: 2017-07-16

Assignee

ALNYLAM PHARMACEUTICALS, INC.

300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142

Covered Properties (8)

Modified Double-Stranded Rna Agents

Patent: 10,612,024 →

Application: 16/272,721 →

Publication: US 2019/0241891

Modified Double-Stranded Rna Agents

Patent: 10,612,027 →

Application: 16/384,644 →

Publication: US 2019/0241893

Modified Double-Stranded Rna Agents

Patent: 11,401,517 →

Application: 16/693,683 →

Publication: US 2021/0017519

Modified Double-Stranded Rna Agents

Application: 17/479,617 →

Publication: US 2022/0002727

Modified Double-Stranded Rna Agents

Patent: 11,427,822 →

Application: 17/523,240 →

Publication: US 2022/0056448

Modified Double-Stranded Rna Agents

Patent: 11,549,109 →

Application: 17/847,550 →

Publication: US 2022/0389424

Modified Double-Stranded Rna Agents

Patent: 12,378,553 →

Application: 17/941,436 →

Publication: US 2023/0110876

Modified Double-Stranded RNA Agents

Patent: 12,168,767 →

Application: 18/145,238 →

Publication: US 2023/0183701

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.

Security Interest Oct 1, 2025

From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.

To: BANK OF AMERICA, N.A.

Reel/Frame 072996/0337 →